KEEPING AN EYE ON BRAIN INJURED PATIENTS
THE PRODUCT
OUR VISION
Bringing Pupillary Monitoring to 21st Century standard;
assisting the medical staff in improving outcomes for brain injured patients
THE NEED
Pupillary reflex assessment is a fundamental and crucial part of the neurological examination. It is a direct indication to brain stem condition, and irregular pupillary response in brain injury cases is an indication that requires immediate clinical attention.
Despite its clinical importance, pupillary examination has not changed in over 100 years, and it is still conducted manually with a conventional light source.
The Need is for an automatic pupil reflex monitoring; assessing neurological status of brain injured patients.
BRAINWATCH
BrainWatch has developed an automatic monitoring system of the pupillary light reflex through closed eyes.
The system is constructed as a head unit and a bedside monitor, using computer vision and AI to continually monitor brain injured patients’ pupillary light reflex without opening their eyes.
The non-invasive system monitors this key indicator automatically, continually, and accurately, the data is analyzed, tracked, and communicated to healthcare professionals.
MEET THE TEAM
Health-tech & high-tech
professional, B.Sc. Mechanical
Engineering & MBA from
Tel Aviv University, Israel
Ilan Carmel
CEO
Head of Endovascular
Neurosurgery unit Hadassah
Ein-Kerm University Hospital,
Jerusalem, Israel
Prof. Jose Cohen
Medical
PhD in Applied Chemistry
from Hebrew University
Jerusalem, Israel
Dr. Yousef Farraj
Project Manager
B.Sc. in Electrical and Computer Engineering
Ben Gurion University,
Negev, Israel
Nir Chechik
Algorithm Engineer
Izik Izhakov
BD Consultant
Dr. Malca Chen Zion
Clinical Consultant
Dr. Nathalie Friedman
IP Consultant
NEWS
BUSINESS NEWS
THE TIMES OF ISRAEL
18 January 2021
Startup hopes to track coma patients’ condition with goggles that monitor pupils.
Israel’s BrainWatch Tech is working on prototype of device that will automatically measure and record pupillary reactions to light in patients with severe brain injury.
IP NEWS
BrainWatch patent
is granted in the US and in Japan
1 January 2022
CLINICAL NEWS
First in Human clinical study
1 June 2022
BrainWatch starts FIH clinical study at Hadassah Medical Center, Jerusalem Israel
WERE HIRING
R&D Manager
BrainWatch is looking for a hands-on creative R&D Manager with knowledge in the fields of computer vision, machine learning, software, and optical systems.
GET IN TOUCH
We would love to hear from you!
Of course, we will respect your privacy, and promise not to pass your mail to any third party.